Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440544
Status:
TERMINATED
Last Update Posted:
2008-11-02
First Post:
2007-02-26
Brief Title:
A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine Ag85B-ESAT6
Sponsor:
St Georges University of London
Organization:
St Georges University of London
Organization Data
Organization:
St Georges University of London
Class:
OTHER
Study ID:
TMUVA-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
St Georges University of London
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
David JM Lewis Principal Investigator
Old Organization:
SGUL
Collaborators
| Name | Class |
|---|---|
| Statens Serum Institut | OTHER |
| Novartis Vaccines | INDUSTRY |
| European Union | OTHER |